UroGen Pharma URGN
NASDAQ URGN
$41.40 +0.85 (+2.10%)
At close: Oct 2, 2026 · 4:00 PM EDT

UroGen Pharma (URGN) Return on Assets [ROA] (2018 - 2026)

Updated

UroGen Pharma's Return on Assets [ROA] came in at -38.57% for Q2 2026, up 29.35 percentage points from -67.92% a year earlier and up 20.10 percentage points from the prior quarter.

Analysis

UroGen Pharma (URGN) Return on Assets [ROA] (2018 - 2026) Analysis & Trends

For FY2025, UroGen Pharma's Return on Assets [ROA] was -63.14%, down 8.46 percentage points from FY2024.

  • Return on Assets [ROA] carries a five-year change of +16.07 percentage points (FY2020 to FY2025).
  • Going back by year, Return on Assets [ROA] was -54.68% in FY2024 (+10.45 pp), -65.14% in FY2023 (+20.84 pp), -85.98% in FY2022 (+5.70 pp) and -91.68% in FY2021 (-12.47 pp).
  • The Q2 2026 figure represents the highest quarterly Return on Assets [ROA] since Q2 2019.
  • Year-over-year, Return on Assets [ROA] increased in four of the last eight quarters, with an average year-over-year change of -3.83 percentage points.
  • The fastest year-over-year change in Return on Assets [ROA] over five years came in Q2 2024 (a gain of 57.61 percentage points), and the weakest in Q3 2025 (a drop of 44.10 percentage points).
  • Business Quant data shows URGN's Return on Assets [ROA] at -58.67% (Q1 2026), -79.63% (Q4 2025) and -83.62% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 20.64%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 10.47%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 4.65%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.45%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 28.37%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.10%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 9.29%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -6.13%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 2.14%
10 UroGen Pharma 2.02 Bn 1.53 Bn 65.88 Mn -38.57%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -38.57%
Mar 31, 2026 -58.67%
Dec 31, 2025 -79.63%
Sep 30, 2025 -83.62%
Jun 30, 2025 -67.92%
Mar 31, 2025 -51.91%
Dec 31, 2024 -43.18%
Sep 30, 2024 -39.53%
Jun 30, 2024 -47.09%
Mar 31, 2024 -55.07%
Dec 31, 2023 -54.98%
Sep 30, 2023 -72.73%
Jun 30, 2023 -104.70%
Mar 31, 2023 -89.80%
Dec 31, 2022 -83.14%
Sep 30, 2022 -79.65%
Jun 30, 2022 -72.95%
Mar 31, 2022 -79.36%
Dec 31, 2021 -87.14%
Sep 30, 2021 -78.30%
API Access

UroGen Pharma Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=URGN&period=max&api_key=YOUR_API_KEY